A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
This multicentre study will assess the safety of atezolizumab as second-line treatment for
participants with locally advanced or metastatic urothelial or non-urothelial cancer of the
urinary tract in addition to evaluate the efficacy of atezolizumab and potential tumour
biomarkers associated with atezolizumab.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society